Tirzepatide Across the Cardiovascular Continuum From HFpEF to cardiorenal protection with a dual GLP-1/GIP agonist. d. 2026;4(21):42-43. Accessed September 17, 2026. https://www.thediabzen.com/index.php/d/article/view/64